# Kane Biotech, Inc.

- Location (FDA's records): Winnipeg, CA
- FDA decisions: 3 (2023–2026): 3 510(k) clearances
- Product codes: FRO (3)
- 510(k) review time since 2016: median 132 days, against 263 for FDA's reviews in the same codes and years (3 of 3 faster)
- Predicates its devices cite: 5 (1 its own); citations of its devices by later devices: 1 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Rochal Industries, LLC: 2 (https://510kreport.com/company/rochal-industries)
- B.Braun Medical, Inc.: 1 (https://510kreport.com/company/b-braun-medical)
- Nawa Heilmittel GmbH: 1 (https://510kreport.com/company/nawa-heilmittel)

## Its most-cited devices
- K223259: coactiv+™ Antimicrobial Wound Gel (2023), cited by 1

## Recent decisions
- K252759: revyve® Antimicrobial Skin and Wound Cleanser (Jan 8, 2026)
- K241809: coactiv+™ Antimicrobial Wound Gel (Jul 19, 2024)
- K223259: coactiv+™ Antimicrobial Wound Gel (May 24, 2023)

Source page: https://510kreport.com/company/kane-biotech